期刊文献+

ApoE基因多态性与冠心病患者抑郁情绪的关系 被引量:12

ApoE Genotype and Depressive Symptoms in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的:了解ApoE基因多态性与冠心病患者抑郁情绪的关系。方法: 用聚合酶链反应扩增技术和限制性片段长度多态性技术(PCR-RFLP)对26例冠心病伴抑郁者、30例冠心病不伴抑郁者和30例健康对照组的载脂蛋白E基因(ApoE)进行分析,用汉密尔顿抑郁量表(HRSD)评定抑郁。结果: 冠心病伴抑郁组的ApoEε4等位基因频率显著高于对照组(P<0.05),而其它等位基因频率在各组中的差异无统计学显著性(P>0.05)。携带ε4等位基因者HRSD(因子分中的运动迟缓、绝望感分)、HAD(包括D因子分和A因子分)总分以及总胆固醇水平均高于非携带ε4等位基因的患者,但在认知损害、体重、睡眠障碍因子得分上的差异没有统计学显著性。结论: ApoE基因多态性与冠心病抑郁情绪有一定的关联,尤其是ApoEε4等位基因在冠心病患者抑郁情绪的发生中可能起重要作用。 Objective:To investigate the relationship between apolipoprotein E (ApoE) genetype and the depressed symptoms in patients with coronary heart disease. Methods:The genotypes and alleles of apolipoprotein E gene in 26 depressed patients with coronary heart disease,30 non-depressed patients with coronary heart disease and 30 healthy control subjects were examined with the polymerase chain reaction (PCR) and restriction fragment length polymorphisms (RFLPs) technique.Meanwhile, the HRSD was completed by all 86 subjects. Results:The frequency of Apolipoprotein E epsilon 4 in depressed patients with coronary heart disease was more than that in normal subjects .Especially the total cholesterol, HRSD and HAD in patients with the apolipoprotein E epsilon 4 were significantly higher than those in patients without the apolipoprotein E epsilon 4. Conclusion:Our results support the polymorphisms of apolipoprotein E gene were associated with the depressed symptoms in coronary heart disease. Apolipoprotein E epsilon 4 may play a major role in the pathogenesis of depressed symptoms in patients with coronary heart disease.
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2005年第1期1-4,共4页 Chinese Mental Health Journal
关键词 APOE基因 多态性 冠心病 抑郁情绪 聚合酶链反应扩增技术 mental health coronary heart disease case-control studies ApoE depression genotype
  • 相关文献

参考文献18

  • 1施慎逊.心境稳定剂治疗[J].上海精神医学,2001,13(1):34-36. 被引量:15
  • 2汪向东 汪向东 王希林 马弘.综合医院抑郁焦虑量表见 心理卫生评定量表手册[J].中国心理卫生杂志,1999,:223-226.
  • 3Wells KB, Rogers W, Bumam MA, et al. Course of depression in patients with hypertension,myocardial infarction or insulin-dependent diabetes. Am J Psychiatry, 1993, 150:632-638.
  • 4Contois JH, Anamani DE, Tsongalis GJ.The underlying molecular mechanism of apolipoprotein E polymorphism:relationships to lipid disorders. Clin Lab Med,1996,16:105-123.
  • 5Cubrilo TM, Stavljenic RA, Sertic J, et al.Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women. Coll Antropol, 1998, 22:149-155.
  • 6Nebes RD,Vora IJ,Meltzer CC,et al.Relationship of deep white matter hyperintensifies and apolipoprotein E genetype to depressive symptoms in older adults without clinical depression. Am J Psychiatry, 2001, 158:878-884.
  • 7Zubenko GS, Stiffler S, Kopp U, et al. Association of the apolipoprotein E ε 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet,1994, 54:199-205.
  • 8Hixson JE and Vernier DT.Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res, 1990, 31:545-548.
  • 9Geroge SZ, Richelle HJ, Scott SS, et al. Association of the ApoE ε 4 allele with clinical subtypes of late life depression. Biol Psychiatry, 1996, 40:1008-1016.
  • 10Poirier J,Davignon J,Bouthillior D,et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet, 1993, 342:697-69911..

二级参考文献12

  • 1[1]Alan F, et al. Manual of clinical psychopharmacology, third edition. Mood stabilizers. American Psychiatric Press, Inc. , 1997,181~221
  • 2[2]Janiczk P G. Handbook of psychopharmacotherapy. Lippincott:Williams & Willkins, 1999, 215~251
  • 3[3]Bowden C L. Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychiatry, 2000, 61(suppl 9) : 35~40
  • 4[4]Tohen M, Grandy S. Management of acute mania. J Clin Psychiatry, 1999, 60(suppl 5) : 31~34
  • 5[5]Bowden C L, Brugger A M, Swarm A C, et al. Efficacy of divalproate vs lithium and placebo in the treatment of mania. JAMA,1994, 271 : 918~924
  • 6[6]Calabress J R, Kimmel S E, Woyshille M J, et al. Clozapine for treatment-refractory mania. Am J Psychiatry, 1996, 153:759~764
  • 7[7]Davis L L, Adinoff B, Petty F. Comprehensiv review of the psychiatric uses of valproate. J Clinical Psychopharmacology, 2000,20(suppl 1) : 1~14
  • 8[8]Calabress J R, Rapport D J. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. J Clin Psychiatry, 1999, 60(suppl 5) : 5~13
  • 9[9]Baldessarini R J, Tondo L. dose lithium treatment still work?Arch Gen Psychiatry, 2000, 57: 187~190
  • 10[10]Shelton R C. Mood stabilizing drugs in depression. J Clin Psychiatry, 1999, 60(suppl 5) : 37~40

共引文献14

同被引文献92

引证文献12

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部